Strategies to improve the quality of survival for childhood brain tumour survivors

Background - Tumours of the central nervous system (CNS) are the most frequent solid tumours and the second most frequent type of cancer in children and adolescents. Overall survival has continuously improved in Germany, since an increasing number of patients have been treated according to standardi...

Full description

Saved in:
Bibliographic Details
Main Authors: Tallen, Gesche (Author) , Witt, Olaf (Author)
Format: Article (Journal)
Language:English
Published: 26 July 2015
In: European journal of paediatric neurology
Year: 2015, Volume: 19, Issue: 6, Pages: 619-639
ISSN:1532-2130
DOI:10.1016/j.ejpn.2015.07.011
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejpn.2015.07.011
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1090379815001397
Get full text
Author Notes:Gesche Tallen, Anika Resch, Gabriele Calaminus, Andreas Wiener, Ulrike Leiss, Thomas Pletschko, Carsten Friedrich, Thorsten Langer, Desiree Grabow, Pablo Hernáiz Driever, Rolf-Dieter Kortmann, Beate Timmermann, Torsten Pietsch, Monika Warmuth-Metz, Brigitte Bison, Ulrich-Wilhelm Thomale, Jürgen Krauss, Martin Mynarek, Katja von Hoff, Holger Ottensmeier, Michael Frühwald, Christof M. Kramm, Petra Temming, Hermann L. Müller, Olaf Witt, Uwe Kordes, Gudrun Fleischhack, Astrid Gnekow, Stefan Rutkowski, on behalf of the German Paediatric Brain Tumour Consortium (HIT-Network)
Description
Summary:Background - Tumours of the central nervous system (CNS) are the most frequent solid tumours and the second most frequent type of cancer in children and adolescents. Overall survival has continuously improved in Germany, since an increasing number of patients have been treated according to standardised, multicentre, multimodal treatment recommendations, trials of the German Paediatric Brain Tumour Consortium (HIT-Network) or the International Society of Paediatric Oncology-Europe (SIOP-E) during the last decades. Today, two out of three patients survive. At least 8000 long-term childhood brain tumour survivors (CBTS) are currently living in Germany. They face lifelong disease- and treatment-related late effects (LE) and associated socioeconomic problems more than many other childhood cancer survivors (CCS). - Method - We review the LE and resulting special needs of this particular group of CCS. - Results - Despite their increasing relevance for future treatment optimisation, neither the diversity of chronic and cumulative LE nor their pertinent risk factors and subsequent impact on quality of survival have yet been comprehensively addressed for CBTS treated according to HIT- or SIOP-E-protocols. Evidence-based information to empower survivors and stakeholders, as well as medical expertise to manage their individual health care, psychosocial and educational/vocational needs must still be generated and established. - Conclusion - The establishment of a long-term research- and care network in Germany shall contribute to a European platform, that aims at optimising CBTSs' transition into adulthood as resilient individuals with high quality of survival including optimal levels of activity, participation and acceptance by society.
Item Description:Gesehen am 29.06.2020
Physical Description:Online Resource
ISSN:1532-2130
DOI:10.1016/j.ejpn.2015.07.011